Despite the well-established effect of chronic eNOS inhibition on stroke outcome [16], the effect of acute inhibition of eNOS on stroke outcome in hypertensive animals and the involvement of eNOS in candesartan-induced neuroprotection and growth factor expression remained undetermined. The gene discussed is NOS3; the disease is stroke disorder.